Commentary|Podcasts|September 30, 2024
Incorporating AI into Commercialization Plans
Author(s)Nicholas Saraceno, Editor
Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.
Advertisement
In this exclusive PC Podcast interview, Steve Silvestro, president of OptimizeRx, a digital communications platform, details:
- The benefits to integrating direct-to-consumer (DTC) and healthcare provider (HCP) marketing strategies with technology, especially for patients and providers
- The application of artificial intelligence (AI) toward the pharma marketing stage of commercialization
- Ways that pharma marketers can navigate the rapidly changing landscape of state-level consumer privacy legislation
- Recommendations for pharma brands as they start to think about 2025 planning
The latest episode of The Pharmaceutical Commerce Podcast is available directly on
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
Pharma Pulse: New CDER Director Appointed, as Medicaid Shows Potential to Save Cancer Lives
4
Strive Pharmacy Breaks Ground on Arizona HQ
5
